Embed Size (px)
Citation preview
Madrid, 13th -15th November, 2019
OncologyGastrointestinal
MD ANDERSON INTERNATIONAL MEETING IN
CURRENT PRACTICE AND CONTROVERSIES
2nd
in th E f iz M ineen the Era of Personalized Medicinenein tthe Era of Personalized Med
Dr. Santiago González-Moreno · MD Anderson Cancer Center Madrid, SpainDr. Miguel A. Rodriguez-Bigas · The University of Texas MD Anderson Cancer Center, Houston, USA
Dr. José María Viéitez · MD Anderson Cancer Center Madrid, Spain
Meeting Directors:
Registrations: www.mdanderson.es/gastrointestinaloncology @MDAnderson_ES
SCIENTIFIC PROGRAM
16:30 - 16:45 WELCOME AND INTRODUCTION Dr. Santiago González-Moreno
MD Anderson Cancer Center Madrid, Spain Dr. Miguel A. Rodriguez-Bigas
The University of Texas MD Anderson Cancer Center, Houston, USA Dr. José María Viéitez
MD Anderson Cancer Center Madrid, Spain
IMMUNOTHERAPY
16:45 - 18:35 SYMPOSIUM: IMMUNOTHERAPY IN GASTROINTESTINAL CANCER
Moderator: Dr. José María Viéitez
MD Anderson Cancer Center Madrid, Spain Dr. Sara Encinas
MD Anderson Cancer Center Madrid, Spain
16:45 - 17:05 Basis of cancer immunotherapy. Does it work in GI tumors? Michael J. Overman
The University of Texas MD Anderson Cancer Center, Houston, USA
17:05 - 17:25 Immunotherapy in gastric cancer Dr. María Alsina
Vall d'Hebron Instituto de Oncología, Barcelona, Spain
17:25 - 17:45 Immunotherapy in pancreatic cancer Dr. Robert A. Wolff
The University of Texas MD Anderson Cancer Center, Houston, USA
17:45 - 18:05 Immunotherapy in hepatocellular cancer Dr. Javier Sastre
Hospital Clínico San Carlos, Madrid, Spain
18:05 - 18:35 Discussion
SCIENTIFIC COMMITTEE
Gastrointestinal Oncology Multidisciplinary Unit,MD Anderson Cancer Center Madrid
SCIENTIFIC COMMITEE COORDINATORS
Dr. Santiago González-MorenoDr. Miguel A. Rodriguez-Bigas
Dr. Jose María Viéitez
MEDICAL ONCOLOGY
Dr. Sara Encinas
RADIATION ONCOLOGY
Dr. Cristina Garrán
DIAGNOSTIC IMAGING
Dr. Raquel SaizDr. Juan Carlos Alonso
SURGICAL ONCOLOGY
Dr. Oscar AlonsoDr. Gloria Ortega
PATHOLOGY
Dr. Ana Teijo
GASTROENTEROLOGY
Dr. Mercedes García-CasasDr. José Luis Calleja
CLINICAL TRIALS
Ms. Belén Bautista
Wednesday, November 13th, 2019
11:00 - 11:45 DEBATE Adjuvant therapy in stage III colon cancer: are 3 months enough?
Moderator: Dr. Sara Encinas MD Anderson Cancer Center Madrid, Spain
11:00 - 11:10 Introduction and voting
11:10 - 11:20 Against Dr. Cathy Eng Vanderbilt University, Nashville, USA
11:20 - 11:30 Pro Dr. Carlos Fernández-Martos Fundación Instituto Valenciano de Oncología, Valencia, Spain
11:30 - 11:40 Discussion
11:40 - 11:45 Voting after debate
11:45 - 13:00 MULTIDISCIPLINARY TUMOR BOARD Moderator:
Dr. Miguel A. Rodriguez-Bigas The University of Texas MD Anderson Cancer Center, Houston, USA
PANEL: Medical Oncology Dr. Cathy Eng Vanderbilt University, Nashville, USASurgical Oncology Dr. Eloy Espín Hospital Universitario Vall d’Hebron, Barcelona, SpainRadiation Oncology Dr. Prajnan Das The University of Texas MD Anderson Cancer Center, Houston, USAMedical Oncology Dr. Elena Élez Hospital Universitario Vall d’Hebron, Barcelona, SpainDiagnostic Imaging Dr. Raquel Saiz MD Anderson Cancer Center Madrid, Spain
PRESENTERS:
11:45 - 12:10 Colorectal clinical case 1
12:10 - 12:35 Colorectal clinical case 2
12:35 - 13:00 Colorectal clinical case 3
13:00 - 14:10 Lunch
COLORECTAL CANCER(non-metastatic)
08:30 - 10:00 MULTIDISCIPLINARY SYMPOSIUM Moderator:
Dr. Miguel A. Rodriguez-Bigas The University of Texas MD Anderson Cancer Center, Houston, USA Michael J. Overman The University of Texas MD Anderson Cancer Center, Houston, USA
08:30 - 08:50 Radiation therapy in rectal cancer: short course vs long course Dr. Prajnan Das The University of Texas MD Anderson Cancer Center, Houston, USA
08:50 - 09:10 Systemic therapies in colorectal cancer. New trends Dr. Cathy Eng Vanderbilt University, Nashville, USA
09:10 - 09:30 Mutated BRAF Dr. Elena Élez Hospital Universitario Vall d’Hebron, Barcelona, Spain
09:30 - 10:00 Discussion
10:00 - 10:30 KEYNOTE LECTURE Presented by:
Dr. Óscar Alonso MD Anderson Cancer Center Madrid, Spain
10:00 - 10:20 Innovation in rectal cancer surgery. TATME. Robotic surgery. Techniques and results
Dr. Eloy Espín Hospital Universitario Vall d’Hebron, Barcelona, Spain
10:20 - 10:30 Questions
10:30 - 11:00 Coffee break
Thursday, November 14th, 2019
METASTATIC COLORECTAL CANCER
14:10 - 16:00 MULTIDISCIPLINARY SYMPOSIUM Moderator:
Dr. Óscar Alonso MD Anderson Cancer Center Madrid, Spain Dr. Ruth Vera Complejo Hospitalario de Navarra, Pamplona, Spain
14:10 - 14:30 Radioembolization in CRC liver metastases and HCC TBC
14:30 - 14:50 Liver transplant for non-resectable liver metastases Dr. René Adam Hôpital Paul Brousse, Université Paris-Sud, Villejuif, France
14:50 - 15:10 ALLPS: indications, technique and results Dr. Ricardo Robles Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
15:10 - 15:30 Can biology help select patients for resection of colorectal liver metastases?
Dr. Jean-Nicolas Vauthey The University of Texas MD Anderson Cancer Center, Houston, USA
15:30 - 16:00 Discussion
16:00 - 16:40 KEYNOTE LECTURE Presented by:
Dr. Gloria Ortega MD Anderson Cancer Center Madrid, Spain
16:00 - 16:30 Update in the treatment of colorectal peritoneal disease. HIPEC. PIPAC
Dr. François Quenet Institut de Cancer de Montpellier, France
16:30 - 16:40 Discussion
16:40 - 17:00 Coffee break
17:00 - 17:45 DEBATE Native Kras left colon cancer, do we know enough to consider anti-EGFR as the standard 1st line treatment?
Moderator: Dr. José María Viéitez MD Anderson Cancer Center Madrid, Spain
17:00 - 17:10 Introduction and voting
17:10 - 17:20 Against Dr. Alfredo Carrato Hospital Universitario Ramón y Cajal, Madrid, Spain
17:20 - 17:30 Pro Dr. Ruth Vera Complejo Hospitalario de Navarra, Pamplona, Spain
17:30 - 17:40 Discussion
17:40 - 17:45 Voting after debate
17:45 - 18:45 MULTIDISCIPLINARY TUMOR BOARD Moderator:
Dr. René Adam Hôpital Paul Brousse, Université Paris-Sud, Villejuif, France
PANEL:Surgical Oncology Dr. Jean-Nicolas Vauthey
The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. François Quenet
Institut de Cancer de Montpellier, FranceSurgical Oncology Dr. Ricardo Robles
Hospital Universitario Virgen de la Arrixaca, Murcia, SpainMedical Oncology Dr. Alfredo Carrato
Hospital Universitario Ramón y Cajal, Madrid, SpainDiagnostic Imaging Dr. Raquel Saiz
MD Anderson Cancer Center Madrid, Spain
PRESENTERS:
17:45 - 18:05 Metastatic disease clinical case 1
18:05 - 18:25 Metastatic disease clinical case 2
18:25 - 18:45 Metastatic disease clinical case 3
TRANSLATIONAL ONCOLOGY
08:30 - 09:40 TRANSLATIONAL ONCOLOGY SYMPOSIUM Moderator: Dr. Juan Fernando García García
MD Anderson Cancer Center Madrid, Spain Dr. Gema Moreno
MD Anderson Cancer Center Madrid, Spain
08:30 - 08:50 Detection of autofluorescent cancer stem cells in colon cancer and their utility in diagnostic tool Dr. Bruno Sainz
Universidad Autónoma de Madrid, Spain
08:50 - 09:10 Pancreas cancer subtypes: clinical relevance Dr. Francisco X. Real
Centro Nacional de Investigaciones Oncológicas-CNIO, Madrid, Spain
09:10 - 09:40 Translational oncology clinical case Dr. Ana Teijo
MD Anderson Cancer Center Madrid, Spain
PANCREATIC TUMORS
09:40 - 11:30 MULTIDISCIPLINARY SYMPOSIUM Moderator: Dr. Cristina Garrán
MD Anderson Cancer Center Madrid, Spain Dr. José Manuel Ramia
Hospital Universitario de Guadalajara, Spain
09:40 - 10:00 Borderline resectable pancreatic cancer Dr. Matthew H.G. Katz
The University of Texas MD Anderson Cancer Center, Houston, USA
10:00 - 10:20 Role of radiation therapy in pancreatic cancer Dr. Prajnan Das
The University of Texas MD Anderson Cancer Center, Houston, USA
10:20 - 10:40 Surgery and transplant in NET liver metastases Dr. Carmelo Loinaz
Hospital Universitario 12 de Octubre, Madrid, Spain
10:40 - 11:00 Role of nuclear medicine in the treatment of metastatic NET Dr. Mercedes Mitjavila
Hospital U. Puerta de Hierro-Majadahonda, Madrid, Spain
11:00 - 11:30 Discussion
11:30 - 12:00 Coffee break
12:00 - 12:30 KEYNOTE LECTURE Presented by: Dr. Santiago González-Moreno
MD Anderson Cancer Center Madrid, Spain
12:00 - 12:20 New therapies in metastatic NET Dr. Enrique Grande
MD Anderson Cancer Center Madrid, Spain
12:20 - 12:30 Discussion
12:30 - 13:15 DEBATE Is neoadjuvant therapy needed in resectable pancreatic cancer?
Moderator: Dr. Ana Ruiz
Hospital U. Puerta de Hierro-Majadahonda, Madrid, Spain
12:30 - 12:40 Introduction and voting
12:40 - 12:50 Pro Dr. Robert A. Wolff
The University of Texas MD Anderson Cancer Center, Houston, USA
12:50 - 13:00 Against Dr. Matthew H.G. Katz
The University of Texas MD Anderson Cancer Center, Houston, USA
13:00 - 13:10 Discussion
13:10 - 13:15 Voting after debate
Friday, November 15th, 2019
13:15 - 13:55 MULTIDISCIPLINARY TUMOR BOARD Moderator: Dr. Carmelo Loinaz
Hospital Universitario 12 de Octubre, Madrid, Spain
PANEL:Medical Oncology Dr. Robert A. Wolff
The University of Texas MD Anderson Cancer Center, Houston, USARadiation Oncology Dr. Prajnan Das
The University of Texas MD Anderson Cancer Center, Houston, USASurgical Oncology Dr. Matthew H.G. Katz
The University of Texas MD Anderson Cancer Center, Houston, USADiagnostic Imaging Dr. Raquel Saiz
MD Anderson Cancer Center Madrid, Spain
PRESENTERS:
13:15 - 13:35 Pancreatic tumor clinical case 1
13:35 - 13:55 Pancreatic tumor clinical case 2
13:55 - 14:00 CLOSING REMARKS Dr. Santiago González-Moreno
MD Anderson Cancer Center Madrid, Spain Dr. Miguel A. Rodriguez-Bigas
The University of Texas MD Anderson Cancer Center, Houston, USA Dr. José María Viéitez
MD Anderson Cancer Center Madrid, Spain
R
Monasterios de Suso y Yuso 34 · 28049 Madrid (+34) 91 372 02 03 e-mail: [email protected]/gastrointestinaloncology
Language:
The official language of the meeting is English.
Accreditation:
Applications for CME credits will be forwarded to the Spanish Accreditation Council for Continuing Medical Education.
With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid.
Organized by:
Venue:
MD Anderson Foundation Spain AuditoriumArturo Soria, 270 28033 Madrid, Spain
Meeting Secretariat:
